Antioxidant activity of plicatin B on cultured human microvascular endothelial cells exposed to H2O2

Drug and Chemical Toxicology

Volumn 30, Issue 4, 2007, Pages 311-325

  Lubrano, V ^a   Boni, G ^b   L'Abbate, A ^c   Turchi, G ^b  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

^b CNR   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

Author keywords

Adhesion molecules; Clastogenicity; Human cell; Metalloproteases; Oxidative stress

Indexed keywords

8 ISOPROSTANE; ANTIOXIDANT; CHALCONE DERIVATIVE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN 1; HYDROGEN PEROXIDE; INTERCELLULAR ADHESION MOLECULE 1; NITRIC OXIDE; PLICATIN B; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; GENOTOXICITY; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; INFLAMMATORY INFILTRATE; LYMPHOCYTE CULTURE; OXIDATIVE STRESS;

ACRYLATES; ANTIOXIDANTS; ATHEROSCLEROSIS; CELLS, CULTURED; ENDOTHELIAL CELLS; HUMANS; HYDROGEN PEROXIDE; LYMPHOCYTES; MICRONUCLEUS TESTS; OXIDANTS; OXIDATIVE STRESS;

EID: 35348837182     PISSN: 01480545     EISSN: 15256014     Source Type: Journal    
DOI: 10.1080/01480540701522148     Document Type: Article

References (56)

1. Achmad, T. H., Rao, G. S. (1992). Chemotaxis of human blood monocytes toward endothelin-1 and the influence of calcium channel blockers. Biochem. Biophys. Res. Commun. 189:994-1000.
2. Ades, E., Kandal, F., Sverlick, R., Gorge, W., Summers, S., Bosse, D. C., Lawley, T. J. (1992). HMEC-1: establishment of an immortalized human microvascular endothelial cell line. Invest. Dermatol. 99:683-690.
3. Alexander, R. W. (1995). Theodore Cooper memorial Lecture. Hypertension and the pathogenesis of atherosclerosis. Oxidative stress and the mediation of arterial inflammatory response: a new perspective. Hypertension 25:155-161.
4. Baldi, S., Maurich, T., Lubrano, V. and Turchi, G. (2003). Antioxidant properties of the chalcone plicatin B. Proceedings of (Eighth International Conference on Mechanisms of Antimutagenesis and Anticarcinogenesis) Ed: Bronzetti, G., Ferguson, L. R., DeFlora, S., Pisa, Italy, 4-8 October, pp. 14.
5. Banting, J. D., Friberg, P., Adams, M. A. (1996). Acute hypertension after nitric oxide synthase inhibition is mediated primarily by increased endothelin vasoconstriction. J. Hypertens 14:975-981.
6. Bath, P., Hassal, D., Gladwin, A., Palmer, R., Martin, J. (1991). Nitric oxide and prostacyclin. Divergence of inhibitory effects on monocyte chemotaxis and adhesion to endothelium in vitro. Arterioscler. Thromb. Vasc. Biol. 11:254-260.
7. Belguendouz, L., Fremont, L., and Linard, A. (1997). Resveratrol inhibits metal ion-dependent and independent peroxidation of porcine low-density lipoproteins. Biochem. Pharmacol. 53:1347-1355.
8. Bevilacqua, M. P. (1993). Endothelial-leukocyte adhesion molecules. Ann. Rev. Immunol. 11:767-804.
9. Bohm, F., Johansson, B. L., Hedin, U., Alving, K., Pernow, J. (2002). Enhanced vasoconstrictor effect of big endothelin-1 in patients with atherosclerosis: relation to conversion to endothelin-1. Atherosclerosis 160:215-222.
10. Bors, W., Heller, W., Michel, C., Saran, M. (1990). Flavonoids as antioxidants: determination of radical scavenging efficiencies. Methods Enzymol. 186:343-355.
11. Bradley, J. R., Johnson, D. R., and Pober, J. S., (1993). Endothelial activation by hydrogen peroxide. Selective increases of intercellular adhesion molecule-1 and major histocompatibility complex class I. Am. J. Pathol. 142:1598-1607.
12. Calliste, C. A., Le Bail, J. C. Trouillas, P., Pouget, C., Habrioux, G., Chulia, A.-J., Duroux, J. l. (2001). Chalcones: structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer. Res. 21:3949-3956.
13. Choi, S. H., Lee, Y., Kim, S. U., Jin, B. K. (2005). Thrombin-induced oxidative stress contributes to the death of hippocampal neurons in vivo: role of microglial NADPH oxidase. J. Neurosci. 25:4082-4090.
14. De Vincenzo, R., Ferlini, C., Distefano, M., Saggini, C., Riva A., Bombardelli, E., Morazzoni, P., et al. (2000). In vitro evaluation of newly developed chalcone analogues in human cancer cells. Cancer Chem. Pharm. 46:305-312.
15. Ducki, S., Forrest, R., Hadfield, J. A., Kendall, A., Nicholas, J. L., McGown, A. T., Rennison, D. (1998). Potent antimitotic and cell growth inhibitory properties of substituted chalcones. Bioorg. Med. Chem. Lett. 8:1051-1056.
16. Farombi, E. O., Nwwaokeafor, I. A. (2005). Anti-oxidant mechanisms of kaloviron: Studies on serum lipoprotein oxidation, metal chelation and oxidative membrane damage in rats. Clin. Exp. Pharm. Physiol. 32:667-674.
17. Fenech, M. (1991). Optimisation of micronucleus assays for biological dosimetry. In: B. L. Gledhill, F. Mauro, Eds. New Horizons in Biological Dosimetry. New York Wiley-Liss, pp. 373-386.
18. Fukuroda, T., Noguchi, K., Tsuchida, S.,Nishikibe, M., Ikemoto, F., Okada, K., Yano, M. (1990). Inhibition of biological actions of big endothelin-1 by phosphoramidon. Biochem. Biophys. Res. Commun. 171:390-395.
19. Garg, U., Hassid, A. (1989). Nitric oxide-generation vasodilatators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J. Clin. Invest. 83:1774-1777.
20. Green, L., Wagner, D., Glogowski, J., Skipper, P., Wishnok, J., Tannenbaum, S. (1982). Analysis of nitrite, nitrate and [15N]nitrate in biological fluids. Anal. Biochem. 126:131-138.
21. Harrison, V. J., Barnes, K., Turner, A. J., Wood, E., Corder, R., Vane, J. R. (1995). Identification of endothelin 1 and big endothelin 1 in secretory vesicles isolated from bovine aortic endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 92:6344-6348.
22. Havsteen, B. H. (2002). The biochemistry and medical significance of the flavonoids. Pharmcol. Ther. 96:67-202.
23. Herencia, F., Ferràndiz, M. L., Ubeda, A., Dominguez, J. N., Charris, J. E., Lobo, G. M., Alcarez, M. J. (1998). Synthesis and anti-inflammatory activity of chalcone derivatives. Bioorg. Med. Chem. Lett. 8:1169-1174.
24. Hinson, J. P., Kapas, S., Cameron, L. A. (1996). Differential effects of endogenous and exogenous nitric oxide on the release of endothelin-1 from the intact perfused rat adrenal gland in situ. FEBS Lett. 379:7-10.
25. Ikeda, M., Schroeder, K. K., Mosher, L. B., Woods, C. W., Akeson, A. L. (1994). Suppressive effect of antioxidants on intercellular adhesion molecule-1 (ICAM-1) expression in human epidermal keratinocytes. J. Invest. Dermatol. 103:791-796.
26. Ikeda, H., Takajo, Y., Murohara, T., Ichiki, K., Adachi, H., Haramaki, N. (2000). Platelet-derived nitric oxide and coronary risk factors. Hypertension 35:904-907.
27. Ikegawa, R., Matsumura, Y., Tsukahara, Y., Takaoka, M., Morimoto, S. (1990). Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting a big endothelin-1 converting enzymes. Biochem. Biophys. Res. Commun. 171:669-675.
28. Ikura, T., Sawamura, T., Shiraka, T., Hosokawa, H., Kido, T., Hoshikawa, H., Shimada, K., Tanzawa, K., Kobayashi, S., Miwa, S., and Masaki, T. (1994). cDNA cloning and expression of bovine endothelin converting enzyme. Biochem. Biophys. Res. Commun. 203:1417-1422.
29. Iwata, S., Nishino, I. S., Nagata, N., Satomi, Y., Nishino, H., Shibata S. (1995). Antitumorigenic activities of chalcones. I. Inhibitory effects of chalcone derivatives on 32Pi-incorporation into phospholipids of HeLa cells promoted by 12-O-tetradecanoyl-phorbol 13-acetate (TPA). Biol. Pharm. Bull. 18:1710-1713.
30. Kahler, J., Mendel, S., Weckmuller, J., Orzechowski, H.-D., Mittmann, C., Koster, R., Martin, P., Meinertz, T., and Munzel, T. (2000). Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J. Mol. Cell Cardiol. 32:1429-1437.
31. Keller, P. M., Lee, C-P, Fenwick, A. E., Atkinson, S. T., Elliot, J. D., DeWolf, W. E. (1996). Endothelin converting enzyme: substrate specificity and inhibition by novel analogs of phosphoramidon. Biochem. Biophys. Res. Commun. 223:372-378.
32. 2 and tumor necrosis factor- activate intercellular adhesion molecule 1 (ICAM-1) gene transcription through distint cis-regulatory elements within the ICAM-1 promoter. J. Biol. Chem. 270:18966-18974.
33. Lawrence, N. J., McGown, A. T., Ducki, S., Hadfield, J. A. (2000). The interaction of chalcones with tubulin. Anti-Cancer Drug Design 15:135-141.
34. Le Bail, J. C., Varnat, F., Nicolas, J. C., Habrioux, G. (1998). Estrogenic and antiproliferative activities on MCF-7 human breast cancer cells by flavonoids. Cancer Lett. 130:209-216.
35. Lerman, A., Holmes., D. R. Jr., Bell, M. R., Garratt, K. N., Nishimura, R. A., Burnett, J. C. Jr. (1995). Endothelin in coronary endothelial dysfunction and early atherosclerosis in human. Circulation 92:2426-2431.
36. Liu, T., Stern, A., Roberts, L. J., Morrow, J. D. (1999). The isoprostanes: novel prostaglandin-like products of the free radical-catalyzed peroxidation of arachidonic acid. J. Biomed. Sci. 58:226-235.
37. Lo, S. K., Janakidevi, K., Lai, L., and Malik, A. B. (1993). Hydrogen peroxide-induced increase in endothelial adhesiveness is dependent on ICAM-1 activation. Am. J. Physiol. 264:1406-1412.
38. Lubrano, V., Vassalle, C., Blandizzi, C., Del Tacca, M., Palombo, C., L'Abbate, A., Baldi, S., Natali, A. (2003). The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides. Eur. J. Clin. Invest. 33:117-125.
39. Maurich, T., Pistelli L., Turchi G. (2004). Anti-clastogenic activity of two structurally related pterocarpans purified from Bituminaria bituminosa in cultured human lymphocytes. Mutat. Res. 561:75-81.
40. McMahon, E. G., Palomo, M. A., Moore, W. M., McDonald, J. F., Stern, M. K. (1991). Phosphoramidon bloks the pressor activity of porcine big endothelin-1(1-39) in vivo and coversion of big endothelin-1(1-39) to endothelin-1-(1-21) in vitro. Proc. Natl. Acad. Sci. U.S.A. 88:703-707.
41. Menon, S. R., Patel, V. K., Mitscher, L. A., Shih, P., Pillai S. P., Shankel, D. M. (1999). Structure-antimutagenic activity relationship study of plicatin B. J. Nat. Prod. 62:102-106.
42. Melidou, M., Riganakos, K., Galaris D. (2005). Protection against nuclear DNA damage offered by flavonoids in cells exposed to hydrogen peroxide: The role of iron chelation. Free. Radic. Biol. Med. 39:1591-1600.
43. Mitscher, L. A., Telikepalli, H., McGhee, E., Shankel, D. M. (1996). Natural antimutagenic agents. Mutat. Res. 350:143-152.
44. Miyauchi, T., Masaki, T. (1999). Pathophysiology of endothelin in the cardiovascular system. Ann. Rev. Physiol. 61:391-415.
45. Mori, T., Cowley, A. W. Jr, Ito, S. (2006). Molecular mechanisms and therapeutic strategies of chronic renal injury: physiological role of angiotensin II-induced oxidative stress in renal medulla. J. Pharmacol Sci. 100:2-8.
46. Morris, C. J., Earl, J. R., Trenam, C. W., Blake, D. R. (1995). Reactive oxygen species and iron a dangerous partnership in inflammation. Int. J. Biochem. Cell Biol. 27:109-122.
47. Patronò, C., FitzGerald, G. A. (1997). Isoprostanes: potential markers of oxidant stress in atherotrombotic disease. Arterioscler. Thromb. Vasc. Biol. 17:2309-2315.
48. Roebuck, K. A., Brenner, D. A., Kagnoff, M. F. (1993). Identification of c-fos-responsive elements downstream of TAR in the long terminal repeat of human immunodeficiency virus type-1. J. Clin. Invest. 92:1336-1348.
49. Ross, R. (1986). The pathogenesis of atherosclerosis-An update. N. Engl. J. Med. 314:488-500.
50. Schmidt, M., Kroger, B., Jacob, E., Seulberger, H., Subkowski, T., Otter, R., Meyer, T., Schmalzing, G., Hillen, H. (1994). Molecular characterization of human and bovine endothelin converting enzyme (ECE-1). FEBS Lett. 356:238-243.
51. Sellak, H., Franzini, E., Hakim, J., Pasquier, C. (1994). Reactive oxygen species rapidly increase endothelial ICAM-1 ability to bind neutrophils without detectable upregulation. Blood 83:2669-2677.
52. Sessa, W., Pritchard, K., Seyedi, N., Wang, J. Hintze, T. (1994). Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ. Res. 74:349-353.
53. Springer, T. A. (1990). Adhesion receptors of the immune system, Nature 344:425-434.
54. Subauste, M. C, Choi, D-C., Proud, D. (2001). Transient exposure of human bronchial epithelial cells to cytokines leads to persistent increased expression of ICAM-1. Inflammation 25:373-379.
55. Van Acker, S. A., van den Berg, D. J., Tromp, M. N., Griffioen, D. H., van Bennekom, W. P., van der Vijgh, W. J., Bast, A. (1996). Structural aspects of antioxidant activity of flavonoids. Free Rad. Biol. Med. 20:275-283.
56. Zhang, C., Hein, T. W., Wang, W., Ren, Y., Shipley, R. D., Kuo, L. (2006). Activation of JNK and xanthine oxidase by TNF-alpha impairs nitric oxide-mediated dilation of coronary arterioles. J. Mol. Cell. Cardiol. 40:247-257.